Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Time Posted：2024-09-23 12:45
In recent years, with the continuous advancement of the Internet wave, the digital transformation of health services has become almost a "must-answer question" for the development of pharmaceutical companies.
【Major News】Top 100 Chinese Pharmaceutical Companies of 2023 Released!
Time Posted：2024-09-07 17:00
The 2024 (41st) National Pharmaceutical Industry Information Annual Conference and the 2023 Top 100 Chinese Pharmaceutical Industry List Release Ceremony, hosted by the China Pharmaceutical Industry Information Center, guided by the China Pharmaceutical Industry Research General Institute, and undertaken by the Sichuan Provincial Department of Economy and Information Technology, opened in Chengdu on September 7.
Time Posted：2024-09-06 17:40
To pay tribute to all the kind-hearted people who have participated in and supported the development of Shenzhen's charitable cause, under the guidance of the Shenzhen Municipal Civil Affairs Bureau, the Shenzhen Charity Federation held the "Shenzhen Charity 20 Years" tribute event on the afternoon of September 5th, the ninth "China Charity Day". The Shenzhen Municipal Civil Affairs Bureau released the "2023 Shenzhen Charity Donation List" at the event.
Time Posted：2024-09-06 12:10
Recently, Jiankechang® (Salmeterol/Fluticasone Propionate inhalation powder) under the Health Yuan Pharmaceutical Co., Ltd. was launched online for the first time on JD Health. This drug is the first domestic generic drug of Seretide®, which was approved for marketing in China in June this year. It can be used for the regular treatment of reversible airway obstructive diseases, including asthma in adults and children. JD Health will give full play to its supply chain advantages to improve the accessibility of this drug, helping more asthma patients control their symptoms and reduce acute attacks.
Time Posted：2024-08-26 12:00
Since the beginning of this year, the innovative drug industry has seen a flurry of favorable policies. From comprehensive support programs to optimized clinical trial review and approval notices, and pilot programs in Beijing and Shanghai, these developments mark a transition in China's innovative drug industry from research and development investment to value realization. However, before these policy benefits are fully realized, a major challenge facing innovative pharmaceutical companies is how to achieve stable operations during this period of industry adjustment. HealthGen has submitted an answer centered on "innovation" and "stability".
Jiankangyuan's anti-influenza drug application for market listing
Time Posted：2024-08-12 17:35
On August 12, the CDE website showed that the marketing application for the influenza drug TG-1000 capsules of Jiankangyuan has been accepted.
2024 Top 100 Pharmaceutical Industry Comprehensive Competitiveness Ranking Released!
Time Posted：2024-08-10 20:00
On August 10th, at the West P Evening Banquet themed "Glory Beyond, Sparkling Stars", the Zhongkang Industry Research Institute released the 2024 Pharmaceutical Industry Comprehensive Competitiveness Index, and based on the index, generated the "2024 Pharmaceutical Industry Comprehensive Competitiveness Top 100 List." 100 benchmark enterprises received industry-wide accolades, composing a hymn of glory.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.